GlassScriptPhysician profile
Matthew John Lommen
NPI 1851915516
$1,476.81
in general payments reported to CMS, 2019-2025
9 companies · $471 in 2025
The $471 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $297 · 2023: $198 · 2024: $510 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,179.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $386.64 | 2024-2025 | General - Embolics, Embold Fibered |
| Balt USA, LLC | $297.25 | 2022 | |
| Medtronic, INC. | $257.92 | 2024-2025 | Mvp, Concertotm |
| Becton, Dickinson and Company | $132.82 | 2025 | Lutonix Drug Coated Balloon |
| Penumbra, INC. | $118.75 | 2025 | Pod |
| Inari Medical, INC. | $113.02 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $85.35 | 2023 | Azur Cx Detachable, Angio-Seal |
| Cordis US Corp. | $70.00 | 2024 | Mynx Control |
| Angiodynamics, INC. | $15.06 | 2024 | Alphavac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Lommen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.